Welcome to our dedicated page for Arcadia Bioscien news (Ticker: RKDA), a resource for investors and traders seeking the latest updates and insights on Arcadia Bioscien stock.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) regularly issues news and updates as a producer and marketer of plant-based and innovative wellness products. With its roots in agricultural innovation and a current focus on Zola coconut water and related wellness offerings, the company’s announcements provide insight into its operating performance, strategic direction, and capital markets activity.
News items for RKDA often include quarterly and annual financial results, where Arcadia reports revenue trends, gross margin performance, and changes in operating expenses. These releases detail how Zola coconut water revenues and distribution have evolved over time, and how asset sales, credit losses, and fair value changes in financial instruments have affected net income or loss attributable to common stockholders.
Arcadia’s news flow also covers strategic transactions and corporate actions. Examples include the sale of its GoodWheat brand and wheat-related intellectual property, agreements to transfer or terminate certain patent rights, and the previously announced but later terminated proposed business combination with Roosevelt Resources, LP. Press releases describe the rationale for these actions and their role in streamlining operations and evaluating strategic alternatives.
Investors following RKDA news will also see capital-raising and securities-related announcements, such as inducement transactions involving preferred investment options and the issuance of new options and placement agent options, as disclosed in company filings and related press releases. In addition, Arcadia publishes notices about upcoming earnings releases, conference calls, and virtual stockholder meetings, along with proxy and governance information.
This news page aggregates these disclosures so readers can review Arcadia’s earnings reports, transaction updates, financing developments, and governance communications in one place. For those tracking RKDA, the feed offers a structured view of how the company describes its business focus, financial condition, and strategic plans over time.
Arcadia Biosciences (Nasdaq: RKDA) has appointed Laura Pitlik as its new chief marketing officer to enhance its consumer goods platforms after key acquisitions. Pitlik, an experienced strategist in consumer packaged goods, will manage brand development and omnichannel marketing for Arcadia's health and wellness portfolio, including brands like GoodWheat and Zola. CEO Matt Plavan highlights this strategic move as a way to position the company for growth in the plant-based food sector, leveraging its innovations in nutrition.
Arcadia Biosciences (Nasdaq: RKDA) reported strong first-quarter financial results for 2021, with revenues increasing by 168% to $828,000, driven by GoodWheat and GLA product sales. The company acquired assets from Lief Holdings and Live Zola, contributing $6 million in annual revenue and expanding its distribution network. However, net income decreased to $2.1 million, down 19% from the previous year, mainly due to non-cash income fluctuations. Operating expenses remained stable at $6.2 million.
On May 17, 2021, Arcadia Biosciences (Nasdaq: RKDA) announced the acquisition of assets from Lief Holdings, LLC and Live Zola, LLC. The deal, valued at $4 million in cash plus 827,400 shares, includes prominent CBD brands such as Soul Spring and Saavy Naturals. This acquisition aims to enhance Arcadia's consumer goods strategy in the CBD market and access distribution channels in over 5,000 stores. With expected annual revenues of $6 million from the acquired brands, Arcadia anticipates revenue growth and operational synergies.
Arcadia Biosciences (Nasdaq: RKDA) will announce its first-quarter financial results on May 17, 2021, after market close. A conference call is scheduled for 4:30 p.m. Eastern time to discuss the results and key strategic achievements for the year. Interested participants can join via U.S. Toll-Free or International Dial-In numbers. The conference call will also be available as a live webcast on the Investors section of Arcadia's website. This session provides an opportunity for investors to gain insights into the company’s performance and future outlook.
Arcadia Biosciences (Nasdaq: RKDA) appointed Belinda Yao as vice president of operations on May 10, 2021. Yao will oversee the supply chain strategy for product manufacturing and production. With over 20 years in management, she brings experience from Zola and The Dannon Company. CEO Matt Plavan stated that Yao's expertise will help build an agile supply chain infrastructure to support the launch of new health and nutrition products. The company focuses on enhancing crop quality and nutritional value through its GoodWheat and GoodHemp brands.
Arcadia Biosciences (Nasdaq: RKDA) has announced that three of its GoodHemp™ seed varieties have received approval from Health Canada, facilitating their sale in Canada. This approval follows certification from the Association of Official Seed Certifying Agencies (AOSCA) and enables Canadian growers to access these high-quality seeds for the 2021 planting season. The approved varieties include Umpqua, Rogue, and Santiam, known for their CBD-dominance and high yield potential. Arcadia has already shipped the first seed order to Tritium 3H, its distribution partner in Canada.
Arcadia Biosciences (Nasdaq: RKDA) announced the acquisition of Agrasys S.A., a Barcelona-based food ingredients company. The deal includes all physical and intellectual property assets of Agrasys, enabling Arcadia to commercialize Tritordeum, a nutritious cereal grain developed by IAS-CSIC. Tritordeum is rich in fiber, protein, and lutein, and is suitable for various foods. Agrasys has already commercialized Tritordeum in 10 countries, including a recent launch with Albert Heijn in Europe. Arcadia aims to expand Tritordeum's market in North America and leverage Agrasys' network for its GoodWheat products.
Arcadia Biosciences, Inc. (RKDA) reported record revenues of $8 million for 2020, up 587% from 2019, driven by significant licensing revenue from Bioceres. The company achieved a net income of $10 million in Q4, compared to a loss in the same quarter the previous year. Arcadia expanded its GoodWheat product line and formed partnerships to enhance its market outreach, including a venture with Three Farm Daughters. Certification of GoodHemp varieties further strengthens its portfolio, while the company is well-funded for future growth. Increased operating expenses were noted, primarily due to R&D and employee-related costs.
Arcadia Biosciences (Nasdaq: RKDA) will release its 2020 fourth-quarter and annual financial results on March 30, 2021, after market close. A conference call is scheduled for 4:30 p.m. ET to discuss these results and the year's strategic achievements. Interested parties can join via U.S. toll-free dial-in or international numbers. The call will be accessible via a live webcast on the company's investor website, with a replay available afterward.
Arcadia focuses on enhancing crop quality and nutrition, with its GoodWheat and GoodHemp brands delivering innovative solutions in the agricultural market.
Arcadia Biosciences, Inc. (NASDAQ: RKDA) has been granted a new patent by the U.S. Patent and Trademark Office for its high fiber resistant starch GoodWheat™, expanding its intellectual property in genome editing. This patent is the 28th for GoodWheat, which offers significant health benefits like eight times the dietary fiber and 30% fewer calories than conventional wheat. Arcadia recently launched premium GoodWheat pasta and flour products through partnerships, enhancing its market presence in North America.